All Stories

  1. Placebo effects in pharmaceutical clinical trials in bronchiectasis: an EMBARC study

    Article • September 2020, European Respiratory Society (ERS)

    Yonghua Gao

  2. The Relationship Between Symptoms, Exacerbations And Treatment Response in Bronchiectasis

    Article • September 2020, European Respiratory Society (ERS)

    Yonghua Gao

  3. Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection

    Article • European Respiratory Journal, May 2020, European Respiratory Society (ERS)

    Yonghua Gao

  4. The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China

    Article • European Respiratory Journal, March 2020, European Respiratory Society (ERS)

    Yonghua Gao

  5. Altered community compositions of Proteobacteria in adults with bronchiectasis

    Article • International Journal of Chronic Obstructive Pulmonary Disease, July 2018, Dove Medical Press

    Yonghua Gao

  6. Inhaled medication therapy for bronchiectasis: status quo and the next frontier

    Article • Expert Opinion on Investigational Drugs, February 2018, Taylor & Francis

    Yonghua Gao

  7. Antibiotic-resistant Pseudomonas aeruginosa infection in patients with bronchiectasis: prevalence, risk factors and prognostic implications

    Article • International Journal of Chronic Obstructive Pulmonary Disease, January 2018, Dove Medical Press

    Yonghua Gao

  8. Anxiety and depression in adult outpatients with bronchiectasis: Associations with disease severity and health-related quality of life

    Article • The Clinical Respiratory Journal, September 2017, Wiley

    Yonghua Gao